State of Alaska Department of Revenue’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

State of Alaska Department of Revenue’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,650	Closed	-$101K	–	1663
2018 Q1	$101K	Buy	1,650 +50	+3%	+$3.01K	﹤0.01%	1560
2017 Q4	$93K	Buy	+1,600	New	+$101K	﹤0.01%	1525

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State of Alaska Department of Revenue's ICPT Position: Q2 2018 in Review

State of Alaska Department of Revenue sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2018, closing a stake of 1,650 shares — an estimated $101K sold.

State of Alaska Department of Revenue first reported a position in ICPT in Q4 2017 and held it in 2 quarters. The position peaked at $101K in Q1 2018. 163 funds tracked by Wall St. Rank hold ICPT as of Q2 2018.

State of Alaska Department of Revenue reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
State of Alaska Department of Revenue sold 1,650 Intercept Pharmaceuticals, Inc. shares in Q2 2018, an estimated $101K.
State of Alaska Department of Revenue first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
State of Alaska Department of Revenue's Intercept Pharmaceuticals, Inc. position peaked at $101K in Q1 2018.
163 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2018.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2018, filed 10 Jul 2018.